MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
about
miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1.Role of microRNAs in inflammation-associated liver cancerTargeting the MET pathway for potential treatment of NSCLC.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.Regulation of the MET oncogene: molecular mechanisms.MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development.MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma.Down-regulation of miR-181a can reduce heat stress damage in PBMCs of Holstein cows.miR-181a Participates in Contextual Fear Memory Formation Via Activating mTOR Signaling Pathway.c-Met and miRs in Cancer.Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
P2860
Q35811902-3646B8FF-3E60-4372-9846-876C2ED27985Q36340244-BD31D0FB-56E0-4AC5-90EC-8D843718D668Q37046372-6322EB2A-50B2-41AC-9212-DDB83F6FAE3BQ37596666-C9ABFAF2-60F9-4E05-ADAF-A5E2C17A69A8Q38297235-91218432-1153-42AF-BA95-98E2068928E1Q38568853-5ECD6E93-01E8-4064-82C1-51F86E75FC88Q38585471-48C33F69-DEC1-4ECD-AEF9-21B072BC4697Q38668774-5DD3C51F-F2D7-4908-8082-A5E3EFD737AEQ38746401-525AABD0-7244-4D93-8B7B-0F000A7A1093Q38823802-6705308C-D153-4A53-8E01-CADB419E70C3Q38858703-B6F53FBA-93A6-47D5-85C8-E348E3BAF528Q38923535-2EEF1E2D-EDB3-4322-AD72-4BAC47B0FC5CQ41818086-C11D034A-5826-4399-AF18-0B0610AD5714Q41994436-2385198E-FD57-4F0A-B68F-862FFD26A1DEQ42251558-677A005E-1331-4EA8-B64C-F76B687AB42EQ42317922-3EB30833-F395-4774-A1E4-5EB2F3A0C8AAQ46555563-CAE95C92-3886-4E30-A2D6-D269AEF191C7Q47608479-586E0129-5797-4938-853E-BE7079EAE4A6Q51158233-86B09571-6D9E-41EB-8247-9EDA02559030Q53221564-DA0E991C-931B-4B84-8E15-73F2FDDFA13AQ58760425-A5455E5D-9D01-401A-858F-E8806D106E30
P2860
MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
MiR-181a-5p is downregulated i ...... s by directly targeting c-Met.
@en
type
label
MiR-181a-5p is downregulated i ...... s by directly targeting c-Met.
@en
prefLabel
MiR-181a-5p is downregulated i ...... s by directly targeting c-Met.
@en
P1476
MiR-181a-5p is downregulated i ...... s by directly targeting c-Met.
@en
P2093
Neşe Atabey
Peyda Korhan
P304
P356
10.1016/J.BBRC.2014.06.142
P407
P50
P577
2014-07-21T00:00:00Z